An Individual Participant Data Analysis: Optimizing Pharmacological Treatment in Children and Adolescents With Major Depressive Disorder

This study investigates how individual characteristics affect the efficacy and tolerability of antidepressants in children and adolescents with major depressive disorder (MDD). By analyzing individual participant data from ten randomized controlled trials, the authors found that fluoxetine was particularly effective in specific subgroups, such as children and females, while highlighting the need for precision medicine approaches in pediatric MDD management. The findings suggest that individual factors like age, sex, and symptom severity can influence treatment outcomes, emphasizing the importance of subgroup analyses in clinical trials.